TGFBR2 and rheumatoid arthritis: The percentage of TGFBR2+ cells present in CD123 + HLA-DR− cell populations was lower in patients with AR (median value 9.1 %, P = 0.03) when compared with HC subjects (median value 15.9 %), but not when compared to patients with AS, RA, or AR + AS.